Jirayu Boonyakida, Kazuhiko Nakayama, Kodai Kusakisako, Hiromi Ikadai, Enoch Y Park
{"title":"Modular Display of <i>Plasmodium yoelii</i> Circumsporozoite Surface Protein and Merozoite Surface Protein-1 on Norovirus-like Particles.","authors":"Jirayu Boonyakida, Kazuhiko Nakayama, Kodai Kusakisako, Hiromi Ikadai, Enoch Y Park","doi":"10.1021/acs.bioconjchem.4c00460","DOIUrl":null,"url":null,"abstract":"<p><p>Recently, virus-like particles have been regarded as a promising platform for displaying foreign peptides or proteins on their surface. In this study, a dual-protein-displaying platform based on the norovirus-like particle (NoV-LP) was developed using SpyTag (SpT)/SpyCatcher (SpC) protein bioconjugation. A short 14-amino-acid SpT peptide was added to the C-terminus of VP1, with a rigid \"EAAAK\" spacer in between. Antigenic proteins from a rodent malaria parasite, <i>Plasmodium yoelii</i>, specifically the circumsporozoite protein (PyCSP) and the 19 kDa C-terminal region of merozoite surface protein 1 (PyMSP1<sub>19</sub>), were displayed on the surface of NoV-LPs in both monovalent and bivalent formats. The immunogenicity of these VLP-based vaccines was assessed, and they were found to induce antigen-specific IgG responses against both PyCSP and PyMSP1<sub>19</sub> in BALB/c mice in the absence of an adjuvant, at levels comparable to those induced by subunit antigenic proteins with an alum adjuvant added. Interestingly, the bivalent vaccine raised IgG responses at a similar titer to the monovalent vaccine. This finding hints that the NoV-LP possesses an inherent adjuvanted property in the presence of a foreign antigen. The measured anti-PyCSP and anti-PyMSP1<sub>19</sub> antibodies through ELISA indicate that surface display of PyCSP and PyMSP1<sub>19</sub> on SpTagged-NoV-LP has the potential for further development as a bivalent vaccine against two different life-cycle stages of malaria.</p>","PeriodicalId":29,"journal":{"name":"Bioconjugate Chemistry Bioconjugate","volume":" ","pages":""},"PeriodicalIF":4.0000,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioconjugate Chemistry Bioconjugate","FirstCategoryId":"1","ListUrlMain":"https://doi.org/10.1021/acs.bioconjchem.4c00460","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
Recently, virus-like particles have been regarded as a promising platform for displaying foreign peptides or proteins on their surface. In this study, a dual-protein-displaying platform based on the norovirus-like particle (NoV-LP) was developed using SpyTag (SpT)/SpyCatcher (SpC) protein bioconjugation. A short 14-amino-acid SpT peptide was added to the C-terminus of VP1, with a rigid "EAAAK" spacer in between. Antigenic proteins from a rodent malaria parasite, Plasmodium yoelii, specifically the circumsporozoite protein (PyCSP) and the 19 kDa C-terminal region of merozoite surface protein 1 (PyMSP119), were displayed on the surface of NoV-LPs in both monovalent and bivalent formats. The immunogenicity of these VLP-based vaccines was assessed, and they were found to induce antigen-specific IgG responses against both PyCSP and PyMSP119 in BALB/c mice in the absence of an adjuvant, at levels comparable to those induced by subunit antigenic proteins with an alum adjuvant added. Interestingly, the bivalent vaccine raised IgG responses at a similar titer to the monovalent vaccine. This finding hints that the NoV-LP possesses an inherent adjuvanted property in the presence of a foreign antigen. The measured anti-PyCSP and anti-PyMSP119 antibodies through ELISA indicate that surface display of PyCSP and PyMSP119 on SpTagged-NoV-LP has the potential for further development as a bivalent vaccine against two different life-cycle stages of malaria.
期刊介绍:
Bioconjugate Chemistry invites original contributions on all research at the interface between man-made and biological materials. The mission of the journal is to communicate to advances in fields including therapeutic delivery, imaging, bionanotechnology, and synthetic biology. Bioconjugate Chemistry is intended to provide a forum for presentation of research relevant to all aspects of bioconjugates, including the preparation, properties and applications of biomolecular conjugates.